Journal of Innovations in Pharmaceutical and Biological Sciences
Read the article
Visual summary · Journal of Innovations in Pharmaceutical and Biological Sciences

Exploring the mechanism of Nigella sativaagainst colorectal cancer by network pharmacology and molecular docking

Ansari Vikhar Danish Ahmad, Misba Ruhi, Subur W Khan, Syed Ayaz Ali, Mohd Mukhtar Khan, Sarfaraz Khan, Qazi Yasar

The question

What potential effects does Nigella sativa have on colorectal cancer?

  • Nigella sativa is also called black cumin or black seed and has a rich history in traditional medicine.
  • The study aimed to explore these effects with network pharmacology and molecular docking.

What was done

Network pharmacologyto identify targets and compounds
Molecular dockingto validate binding interactions
  • Network pharmacology analysis was used to identify relevant colorectal cancer targets and compounds drawn from databases.
  • Protein-protein interaction (PPI) and KEGG (Kyoto Encyclopedia of Genes & Genomes) pathway analyses mapped critical molecular pathways.
  • Molecular docking simulations were used to validate binding interactions at active sites.

Key findings

Finding 1 of 4
319 nodes
and 410 edges in the network of compound-target interactions

The network of compound-target interactions had 319 nodes and 410 edges, which the authors read as a complex interplay of the derivatives and their targets.

Finding 2 of 4
PPI analysis
underscored significant interactions with targets involved in colorectal cancer regulation

The PPI analysis underscored significant interactions within the network, in particular with targets known to take part in the regulation of colorectal cancer.

Finding 3 of 4
EGFR and PI3K
pathways highlighted by KEGG pathway analysis in colorectal cancer

KEGG pathway analysis pointed to the importance of the EGFR and PI3K pathways in colorectal cancer.

Finding 4 of 4
Nigellicine
showed the strongest affinity for key targets linked to colorectal cancer in docking

In the molecular docking studies, the highest affinity for key targets related to colorectal cancer was that of Nigellicine; the targets include ALB (-7.1 kcal/mol), HSP90AA1 (-8.2), IL6 (-6.2 kcal/mol) and AKT1 (-7.6 kcal/mol).

Why it matters

  • The authors stress that further research is needed to develop pharmacological interventions for managing colorectal cancer.
  • The authors draw on network analysis combined with molecular docking studies.

How to cite

Ansari Vikhar Danish Ahmad, Misba Ruhi, Subur W Khan, Syed Ayaz Ali, Mohd Mukhtar Khan, Sarfaraz Khan, et al. Exploring the mechanism of Nigella sativaagainst colorectal cancer by network pharmacology and molecular docking. Journal of Innovations in Pharmaceutical and Biological Sciences. 2024;11(01):10-24. https://doi.org/10.56511/jipbs.2024.11102

Open the article